ATE160376T1 - Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert - Google Patents

Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert

Info

Publication number
ATE160376T1
ATE160376T1 AT91915865T AT91915865T ATE160376T1 AT E160376 T1 ATE160376 T1 AT E160376T1 AT 91915865 T AT91915865 T AT 91915865T AT 91915865 T AT91915865 T AT 91915865T AT E160376 T1 ATE160376 T1 AT E160376T1
Authority
AT
Austria
Prior art keywords
marek
glycoprotein
codes
dna segment
herpes virus
Prior art date
Application number
AT91915865T
Other languages
English (en)
Inventor
Leland F Velicer
Peter Brunovskis
Paul M Coussens
Original Assignee
Univ Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27075921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE160376(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/572,711 external-priority patent/US5138033A/en
Application filed by Univ Michigan State filed Critical Univ Michigan State
Application granted granted Critical
Publication of ATE160376T1 publication Critical patent/ATE160376T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91915865T 1990-08-24 1991-08-19 Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert ATE160376T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/572,711 US5138033A (en) 1990-08-24 1990-08-24 Marek's disease herpesvirus glycoproteins GE
US07/736,335 US6087127A (en) 1990-08-24 1991-07-25 Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE

Publications (1)

Publication Number Publication Date
ATE160376T1 true ATE160376T1 (de) 1997-12-15

Family

ID=27075921

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915865T ATE160376T1 (de) 1990-08-24 1991-08-19 Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert

Country Status (11)

Country Link
US (2) US6087127A (de)
EP (1) EP0502146B1 (de)
JP (1) JP2527872B2 (de)
AT (1) ATE160376T1 (de)
AU (1) AU636247B2 (de)
CA (1) CA2066160A1 (de)
DE (1) DE69128239T2 (de)
DK (1) DK0502146T3 (de)
ES (1) ES2110999T3 (de)
GR (1) GR3025821T3 (de)
WO (1) WO1992003547A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0473210B1 (de) * 1990-07-30 1994-04-13 Akzo Nobel N.V. Rekombinantes Mareks-Krankheitsvirus
AU657144B2 (en) * 1991-07-09 1995-03-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US6875856B2 (en) 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
EP0822980A4 (de) * 1995-03-23 2000-04-26 Syntro Corp Rekombinantes infektiöses laryngotracheitisvirus und dessen verwendung
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
GB0313132D0 (en) * 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
CN116042709B (zh) * 2022-09-23 2025-01-14 广西大学 一种共表达马立克病病毒糖蛋白gC和gD的DNA疫苗构建方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3339854B2 (ja) * 1988-09-13 2002-10-28 メリアル ウイルスワクチン
EP0473210B1 (de) * 1990-07-30 1994-04-13 Akzo Nobel N.V. Rekombinantes Mareks-Krankheitsvirus
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
DE69333728T2 (de) * 1992-01-13 2006-08-31 Virogenetics Corp. Redombinanter Poxvirus als Impfstoff gegen den Virus der Marek-Krankheit.

Also Published As

Publication number Publication date
WO1992003547A1 (en) 1992-03-05
JP2527872B2 (ja) 1996-08-28
CA2066160A1 (en) 1992-02-25
EP0502146A1 (de) 1992-09-09
EP0502146B1 (de) 1997-11-19
JPH04505106A (ja) 1992-09-10
AU636247B2 (en) 1993-04-22
AU8496591A (en) 1992-03-17
ES2110999T3 (es) 1998-03-01
DK0502146T3 (da) 1998-07-27
DE69128239T2 (de) 1998-03-12
EP0502146A4 (de) 1994-08-03
US5976787A (en) 1999-11-02
GR3025821T3 (en) 1998-03-31
US6087127A (en) 2000-07-11
DE69128239D1 (de) 1998-01-02

Similar Documents

Publication Publication Date Title
EP0841941A4 (de) Neuartige nicht pyrogene bakterienstämme und ihre verwendung
ATE258188T1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
ATE267258T1 (de) Impfstoffe für das respiratorische-synzytial- virus mit nuklein säuren
HUT69803A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
ES2009350A6 (es) Procedimiento para la preparacion de vectores de expresion que codifican una nueva proteina.
ES2193133T3 (es) Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines.
NO874750L (no) Bestemte dna-sekvenser avledet fra et papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater.
ATE60799T1 (de) Virus-impfstoff.
NO20000850D0 (no) Vaksine
BR9712592A (pt) Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico
ES8203226A1 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
HUP9901112A2 (hu) Szintetikus HIV-gének
DK1108035T3 (da) Behandling af cervixcancer
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
ATE160376T1 (de) Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert
HUP9801334A2 (hu) A 18-as típusú humán papillomavírust kódoló DNS
ES8505253A1 (es) Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex.
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
ATE159170T1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
PT586076E (pt) Vacinas de adenovirus recombinantes
ATE223492T1 (de) Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
MX9605139A (es) Linea celular de pollo, sostenible, infectada con el virus de la enfermedad de marek.
DE69131984D1 (de) Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung
MX9602256A (es) Vacuna contra la enfermedad de marek.